SCHEMBL320423

SCHEMBL320423

CC(C)C1CCCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13416392 1.00
SCHEMBL14038810 1.00
SCHEMBL18531650 0.97 SLC6A2 (0.47)
Bromide SCHEMBL11542096 0.97 SLC6A2 (0.47)
SCHEMBL7897603 0.97 SLC6A2 (0.47)
SCHEMBL24375671 0.97 SLC6A2 (0.47)
SCHEMBL4762840 0.92
SCHEMBL1104709 0.92
SCHEMBL489437 0.92
Hydrochloric Acid SCHEMBL25316432 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 382 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106622359-B A kind of SSZ-39/ZSM-5 composite molecular screen and its synthetic method and application 中触媒新材料股份有限公司 2019-03-08 CN claimed
CN-106745057-B The AEI/MFI eutectics Si-Al molecular sieve and synthetic method of a kind of binder free and application 中触媒新材料股份有限公司 2018-11-13 CN claimed
WO-2013177284-A1 HAFNIUM-CONTAINING PRECURSORS FOR VAPOR DEPOSITION L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2013-11-28 WO claimed
WO-2013177292-A1 TITANIUM-CONTAINING PRECURSORS FOR VAPOR DEPOSITION L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2013-11-28 WO claimed
WO-2013177269-A2 ZIRCONIUM-CONTAINING PRECURSORS FOR VAPOR DEPOSITION L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2013-11-28 WO claimed
US-20260078117-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS INC (US) 2026-03-19 US disclosed
US-12304907-B2 Compounds and methods of use TANGO THERAPEUTICS, INC. (US) 2025-05-20 US disclosed
US-12281060-B2 Remodilins for airway remodeling and organ fibrosis THE UNIVERSITY OF CHICAGO (US) 2025-04-22 US disclosed
US-12264154-B2 Compounds and methods of use TANGO THERAPEUTICS, INC. (US) 2025-04-01 US disclosed
US-20240415851-A1 REMODILINS TO PREVENT OR TREAT CANCER METASTASIS, GLAUCOMA, AND HYPOXIA THE UNIVERSITY OF CHICAGO (US) 2024-12-19 US disclosed
US-20240279219-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-08-22 US disclosed
US-20240239835-A9 NEUROACTIVE STEROIDS AND THEIR METHODS OF USE SAGE THERAPEUTICS, INC. 2024-07-18 US disclosed
WO-2005037805-A2 1,2,4-THIADIAZOLE COMPOUNDS AND PESTS CONTROLLING COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-04-28 WO disclosed
EP-1455777-A1 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS SMITHKLINE BEECHAM PLC (GB) 2004-09-15 EP disclosed
US-20040092679-A1 Process for producing catalyst for alpha-olefin polymerization and process for producing alpha-olefin polymer SUMITOMO CHEMICAL COMPANY, LIMITED 2004-05-13 US disclosed
US-6680360-B2 STEREOSPECIFIC POLYMERIZATION CATALYSTS FORMED BY REDUCING TITANIUM COMPOUND WITH ORGANOMAGNESIUM COMPOUNDS IN THE PRESENCE OF ORGANOSILICON COMPOUND AND ACIDS, TO FORM SOLIDS CONTAINING TITANIUM, ORGANOALUMINUM AND SILICON COMPOUNDS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-01-20 US disclosed
CN-1432583-A Process for producing alpha-olefin polymerization catalyst and process for producing alpha-olefin polymer SUMITOMO CHEMICAL CO (JP) 2003-07-30 CN disclosed
US-20030134992-A1 Process for producing catalyst for alpha -olefin polymerization and process for producing alpha -olefin polymer SUMITOMO CHEMICAL COMPANY, LIMITED 2003-07-17 US disclosed
WO-2003055478-A1 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 2003-07-10 WO disclosed
WO-2003055478-A1 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 2003-07-10 WO disclosed